logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

西、義兩天奪3千命 WHO稱高峰後疫情趨緩

新冠病毒這兩天,奪走義大利和西班牙一共3千條人命。西班牙確診病例超越中國是全球第三多,義大利確診數也突破10萬人。世衛組織分析指出,這兩國即將迎來疫情高峰期,之後就會開始趨緩。

世界衛生組織(WHO)表示,歐洲新冠疫情極為嚴重的義大利和西班牙近日出現疫情趨穩跡象,此一現象説明先前採取的「社交隔離」等防控措施已開始生效。

世衛組織衛生緊急項目負責人瑞安在記者會上表示,由於持續採取嚴格防控措施,義大利和西班牙新增病例的曲線將逐漸平緩,世衛組織也熱切期望兩國疫情能夠趨於穩定。瑞安説,目前兩國疫情曲線實際上應是反映了至少兩周前狀況。他表示,通過「社交疏離」措施,每個確診病例的接觸者數量在明顯減少,這意味著與兩周前相比,處於感染風險的人數已大量減少。再加上持續對社區病例的檢測和隔離,人們其實已能夠搶在病毒進一步擴散前採取措施。據義大利官方統計,周日新增確診感染病例減少5.6%,這已經是確診病例連續第3天呈下降趨勢。

另外,西班牙公衛官員表示,自從14日實施封城措施後,相較之前每天20%增幅,現在確診增幅約為每天12%,死亡人數及新增病例的增長率皆放緩,期望已經接近疫情的高峰。但西班牙周一新增新增849起武漢肺炎死亡病例,累計死亡人數達8189人,創單日新高。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 美國海軍醫療船「舒適號」今抵紐約
Next post 波音向員工提出「自願離職」計劃減輕財務壓力

即時新聞

賓州警方執行搜捕令時遭槍擊 致三死兩傷

September 18, 2025

賓州警方執行搜捕令時遭槍擊 致三死兩傷

September 18, 2025

川普與英相施凱爾簽署科技協議 加強美英合作

September 18, 2025

擬重新設計堅尼路 紐約市交通局徵詢公眾意見

September 18, 2025

聯大會議和猶太新年將至 紐約市警公佈安全計劃

September 18, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy